Sixty billion yen of net cash sits on a ¥74B market cap. What management does with it decides everything.

• Cheap is the easy part. EV/EBITDA 0.6×, P/E 4.5×, P/B 0.33×. Net cash of ¥59B equals 81% of the share price — the operating engine is priced at roughly half a year's EBITDA.
• The bull bet — payout follows through. FY25 guides 84% total payout via DOE 3.5% plus buyback. A ¥1.43B March 2026 Treasury purchase already printed; share count fell from 36.19M to 35.53M.
• The bear bet — fourth-business M&A. The mid-term plan earmarks ¥60–100B for an unannounced fourth pillar by FY30. The same 47.8% Nishimoto family that fired the entire board in 2008 still controls the cap table.

Three subsidiaries, one matters. AlphaTheta is 73% of group EBITDA and the global DJ-rider standard.

AlphaTheta is fabless — production outsourced — so the next yen of DJ-equipment revenue drops through at near-100% gross margin once hardware is designed. That mechanic produced the FY24 group EBITDA margin of 22.8% on revenue growth alone. The risk to underwrite over the next 18 months is whether an own-factory commitment converts a 28%-margin asset-light business into one funding capex against a much lower incremental return.

The marginal buyer is screening the wrong company.

• Stale databases. Morningstar's company description still lists healthcare, drug discovery, senior life and agribusiness as primary segments — businesses exited or monetised between 2016 and 2024. Google Finance lists the wrong CEO.
• Two analysts. That is it. A ¥74B holdco with three globally-dominant niches has near-zero institutional research footprint. The mean target of ¥3,110 implies 52% upside; the multiple has not moved off 0.4× P/B in nine years.
• The unlock is mechanical. The July 2025 3:1 split brought the per-share entry from ¥6,150 to ¥2,047 — Japanese retail screens see the name for the first time, and ROE crossing 8% on the FY25 print triggers TSE-Prime quant-screen inclusion.

FY24 produced the best margins of the decade against the strongest balance sheet ever held.

A ¥101.5B JMDC disposal gain in FY22 funded the cash-positive flip; subsequent operating leverage from AlphaTheta's fabless model and a ¥7.1B yen tailwind on revenue pushed the operating margin from 1.7% in FY22 to 19.3% in FY24. The hole in the story is ROE — at 7.5% it sits below the 8% TSE-Prime quant threshold, and the equity base keeps growing faster than earnings until the buyback pace accelerates.

Sixteen days to a print that resolves three threads at once.

• May 15 — Q1 FY26 results. First quarter consolidating SENQCIA, the $519M Lone Star carve-out closed April 28. The PPA disclosure shows the goodwill ratio — the bear's 'cash deployed at any price' priors stand or fall on this number.
• JLab tariff response. Management modelled a ¥2.9B EBITDA hit from US reciprocal tariffs offset by ¥2.4B of price hikes; $20-earbud price elasticity is the unverified assumption. Q1 segment gross margin reveals whether the offset works.
• Capital return cadence. ¥1.46B of the ¥3B buyback authorisation is residual after the March execution. A follow-on tranche before the AGM resolutions stale forces the bear to reweight the controller-extraction priors.